The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on October 1, 2026

CompoSecure, 프리미엄 금속카드 글로벌 수요 증가에 대응해 런던 디자인 센터 개소
CompoSecure Membuka Pusat Reka Bentuk Baharu di London bagi Memenuhi Permintaan Antarabangsa yang Semakin Meningkat terhadap Kad Logam Premium
CompoSecure Inaugura Centro de Design em Londres para Atender à Crescente Demanda Internacional por Cartões de Metal Premium
CompoSecure 伦敦设计中心开业,满足国际市场对高端金属卡日益增长的需求
CompoSecure 於倫敦開立新設計中心,以滿足國際對優質金屬卡日益增長的需求
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FmPro Migrator Custom Dev Edition 11.85 Adds Fixed-Price CakePHP 5 Conversions for FileMaker Pro & Visual FoxPro
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
STACK Infrastructure Achieves SBTi Validation of Science-Based Net-Zero Targets
Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants
ESCO Completes Acquisition of Megger Group Limited
NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer
NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering
WISeSat.Space Holdings Corp. Announces Closing of Business Combination with Columbus Acquisition Corp.
WISeKey’s Redomiciliation from Switzerland to the British Virgin Islands Becomes Legally Effective
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Digital Realty Schedules Third Quarter 2026 Earnings Release and Conference Call
Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026
Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The California STEM Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.